Aseptika Ltd
About
WHAT WE DO
Support clinicians to deliver “blended” healthcare services (hybrid delivery) of in-person and video consultations, supported with digital remote monitoring and digital patient education to improve health outcomes, reduce the burden on clinical staff and enable a safe increase in the ratio of patients to clinical staff.
PLATFORM
Certified as a Class I medical device (CE and UKCA marked). Developed to ISO 13485:2016.
OUR PRODUCTS
Asthma+me: Hybrid care for Children and Young People with severe asthma at risk of hospitalisation from a further asthma attack. Includes: Spirometer, Smart Inhaler trackers, Asthma+me App, clinically reviewed education programmes for both Children and Young People and their adult Parents or Carers.
Active+me REMOTE Cardiac Rehabilitation and Heart Failure. Two dedicated hybrid delivery programmes for patients following a cardiac event and separately, long-term support of patients with Heart Failure. Includes
Remote monitoring, video consultations, pre-recorded and live delivery of exercise classes, a paced-walking programme and the ability for patients to track levels of breathlessness or exertion.
Active+me REMOTE for Pulmonary Rehabilitation. Designed to support patients at any stage of their rehabilitation for respiratory disease. Includes patient-level alerts, symptom tracking, changes in physiological signs and adherence to medication with smart inhaler trackers.
Key Facts
- Hybrid Cardiac Rehabilitation delivered during the pandemic using the Active+me REMOTE product achieved:
- Increase in Patient Activation Scores from 65.5 at baseline to 70.2 (greatest increase from 61.9 to 75.0 in High-Risk groups).
- Reduction in resting systolic blood pressure by 6mmHg.
- Decrease in waist circumference by 7.5 cm.
- Increase in self-reported physical activity.
- Completion of the programme with Active+me REMOTE was 93.4% (in-person UK completion rate 77% nationally).
Successes in UK/NHS
Our products and platforms are now used in 8 NHS hospitals in the UK.
Results from a real-world evaluation at Cambridge’s Addenbrookes Hospital have been published in a peer-reviewed journal (December 2021).
https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-021-07363-7#Tab3
Organisation details
Website
www.activ8rlives.com ↗Markets already exporting to
Ireland Brazil
Desired Markets
Australia, Canada, EU, New Zealand, USA.
Desired customer types
Hospitals, government health systems and private groups.
Solutions